Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Asset disposition
Cert. of designation
Director departure
Appointed director
|
|
ALIMERA SCIENCES INC (ALIM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2012 |
8-K
| Asset disposition, Certificate of designation filed, Appointed a new director|
Docs:
|
"EX-3.4(C)",
"Certificate of Designation of Series A Convertible Preferred Stock",
"EX-4.10(A)",
"EX-4.10(B)",
"EX-4.10(C)",
"EX-4.10(D)",
"EX-4.10(E)",
"Registration Rights Agreement",
"Amendment No. 1 to Securities Purchase Agreement",
"ALIMERA SCIENCES CLOSES $40 MILLION FINANCING Stockholders Approve the Issuance of Series A Preferred Stock and Warrants ATLANTA, GA. October 2, 2012 — Alimera Sciences, Inc. , a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has completed the sale of $40 million of Series A Convertible Preferred Stock and warrants to purchase Series A Preferred to a group of institutional investors, including both existing and new investors, in a private placement. On October 1, 2012, the Company held a special stockholders meeting at which the stockholders approved the issuance of Series A Preferred and Warrants pursuant to applicable NASDAQ Listing Rules. “We believe the closing of this fin..." |
|
|
|